Back
Speaker illustration

Doctor Melly Susanti

Ministry of Health Surabaya Central General Hospital, Jawa Timur (Indonesia)

Member of:

European Society of Cardiology

Melly Susanti, MD is a cardiologist and interventional fellow at Korea University Guro Hospital, Seoul. Since starting her fellowship in February 2025, she has been training in complex coronary and peripheral interventions, with particular interests in chronic total occlusion (CTO) PCI, intravascular imaging (IVUS/OCT), and endovascular therapies. Before her fellowship, Dr. Susanti worked as a cardiologist at the Ministry of Health Hospital Surabaya, in collaboration with the National Cardiovascular Center Harapan Kita, Indonesia. She completed her cardiology residency at Universitas Airlangga and Dr. Soetomo General Hospital, Indonesia. She has contributed to research on endothelial function, cardiac amyloidosis, and cardiovascular pharmacotherapy, with several peer-reviewed publications. Outside of clinical practice, Dr. Susanti is dedicated to cardiovascular health education and actively creates content to raise public awareness about heart disease.

Presentations

Impact of Carvedilol versus Bisoprolol on long-term clinical outcomes in STEMI patients with mid-range LVEF

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Novel pharmacological approaches following an acute coronary syndrome

Access
Like
Thumbnail

Impact of 2nd-generation versus 3rd-generation beta-blockers on long-term clinical outcomes in STEMI patients treated with drug-eluting stents

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Chronic coronary syndromes: prognosis

Access
Like
Thumbnail

Long-term clinical outcomes in patients with coronary artery spasm according to first responsive dose of intracoronary acetylcholine

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Atypical coronary syndromes

Access
Like
Thumbnail

Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

Event: ESC Congress 2025

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Pharmacotherapy in acute coronary syndromes (1)

Access
Like
Thumbnail

Impact of biodegradable-polymer versus durable-polymer drug-eluting stents on clinical outcomes in patients with chronic total occlusion underwent successful percutaneous coronary intervention

Event: ESC Congress 2025

Topic: Revascularisation

Session: Advanced invasive strategies in chronic coronary syndromes

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources